Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes: "Diabetic nephropathy is an increasingly common cause of end-stage renal disease, and the development and rate of renal deterioration are most closely related to the patient's blood pressure. Guideline committees worldwide concur that the blood pressure in patients with diabetes and chronic kidney…"